Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Bellerophon Therapeutics Inc BLPH

Healthcare Biotechnology
Bellerophon Therapeutics, Inc. is a clinical-stage therapeutics company. The Company is focused on developing products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. The Company’s focus is to develop its nitric oxide therapy for patients with pulmonary hypertension (PH) using its delivery system, INOpulse. The Company’s INOpulse program is an... see more

Recent & Breaking News (GREY:BLPH)

12 Biggest Mid-Day Gainers For Monday

Benzinga.com  March 20, 2017

Bellerophon Reports Fourth Quarter 2016 Financial Results and Provides Business Update

GlobeNewswire March 13, 2017

Biotech and Pharma Stocks Rise on Optimism in the Markets Fueling Acquisitions and new Product Launches

PR Newswire Europe Non Regulatory March 7, 2017

How These Biotech Stocks are Faring? -- Geron, Incyte, Illumina, and Bellerophon Therapeutics

PR Newswire March 3, 2017

Bellerophon Therapeutics Announces FDA Acceptance of Modifications to INOpulse Pulmonary Arterial Hypertension Phase 3 Program

GlobeNewswire January 4, 2017

Who Else Might Johnson & Johnson Seek To Acquire With Actelion Now Out Of Its Crosshairs?

Benzinga.com  December 14, 2016

Bellerophon Therapeutics, Inc. Announces $12 Million Public Offering

GlobeNewswire November 23, 2016

Bellerophon Reports Third Quarter 2016 Financial Results and Provides Business Update

GlobeNewswire November 8, 2016

INVESTOR ALERT: Goldberg Law PC Announces an Investigation of Bellerophon Therapeutics, Inc. and Advises Investors with Losses to Contact the Firm

Business Wire November 1, 2016

Robbins Arroyo LLP is Investigating the Officers and Directors of Bellerophon Therapeutics, Inc. (BLPH) on Behalf of Shareholders

Business Wire November 1, 2016

SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman, LLC Announces Investigation of Bellerophon Therapeutics, Inc. (BLPH)

PR Newswire November 1, 2016

INVESTOR ALERT: Investigation of Bellerophon Therapeutics, Inc. Announced by Law Offices of Howard G. Smith

Business Wire October 28, 2016

Johnson & Weaver, LLP Initiates Investigations of Bellerophon Therapeutics, Inc., KemPharm, Inc., Neos Therapeutics, Inc., CommVault Systems, Inc. and Resource Capital Corp.

PR Newswire October 26, 2016

Bellerophon Therapeutics Announces Planned Management Transition by Year-End 2016

GlobeNewswire September 20, 2016

Bellerophon to Present at the 18th Annual Rodman & Renshaw Global Investment Conference

GlobeNewswire September 6, 2016

Bellerophon Reports Second Quarter 2016 Financial Results and Provides Business Update

GlobeNewswire August 9, 2016

Mid-Day Market Update: Crude Oil Down 2%; Outerwall Shares Spike Higher

Benzinga.com  July 25, 2016

13 Stocks Moving In Monday's Pre-Market Session

Benzinga.com  July 25, 2016

Bellerophon Receives Approval to Commence Phase 2 Trial in PH-COPD

GlobeNewswire July 25, 2016

Bellerophon Therapeutics Announces Enrollment of the First Patient in the INOvation-1 Phase 3 Clinical Trial for Pulmonary Arterial Hypertension (PAH)

GlobeNewswire June 16, 2016